Healthcare -
Biotechnology - NASDAQ - US
$ 6.195
-13.2 %
$ 974 M
Market Cap
-4.8
P/E
OCUL - STOCK-BASED COMPENSATION
Stock-based Compensation OCUL - Ocular Therapeutix, Inc.
17.8 M
LAST VALUE
9.09%
2 YEAR CAGR
18.96%
5 YEAR CAGR
43.66%
10 YEAR CAGR